Inventor
Donald R. Kirsch
Inventor
Princeton, NJ, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
C12NMicroorganisms or enzymes13%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms13%
C07KPeptides10%
A61KPreparations for medical, dental or toiletry purposes8%
C07DHeterocyclic compounds8%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests8%
C07CAcyclic or carbocyclic compounds6%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture6%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms4%
PatentTitleYear
10,167,263Treatment of amyotrophic lateral sclerosis20199,593,069'Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis'20179,499,494'Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis'20169,162,968'Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis'20158,722,939'Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis'20147,329,663'Substituted-triazolopyrimidines as anticancer agents'20087,148,053'Heterologous G protein coupled receptors expressed in yeast, their fusion with G proteins and use thereof in bioassay'20066,607,906'Heterologous G protein coupled receptors expressed in yeast, their fusion with G proteins and use thereof in bioassay'20036,589,762'Calcafluor screen for chitin biosynthesis inhibitors'20036,406,871'Method for detecting ligand binding to G protein coupled receptors'20026,387,647'Cytochrome P-450 reductase screen for ergosterol biosynthesis inhibitors'20026,110,698'Screen for ultraspiracle inhibitors'20005,846,819'Recombinant expression vectors for expression of heterologous proteins'19985,691,188'Transformed yeast cells expressing heterologous G-protein coupled receptor'19975,591,576'Sterol .DELTA.14 reductase screen'19975,527,687'Enzyme induction screen for ergosterol biosynthesis inhibitors'19965,525,496'DNA sequence encoding sterol .DELTA.14 reductase'19965,512,472'DNA sequence encoding sterol .DELTA.14 reductase'19965,418,144'Spindle pole body screen for fungicides'19955,294,725'Scopularin'19945,024,839'Dactylocycline A and dactylocycline B'19914,754,018'Antibiotic prepared from lysobacter sp. SC 14,067 and analogs thereof'19884,735,901'Transformation of Candida albicans'19884,719,109'EM5596--an antibiotic'1988Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1988–1994Patents assigned to SQUIBB & SONS INC (5)· patent assignee history
1988–2008Based in Princeton, NJ, US· patent location history
1995–2000Patents assigned to AMERICAN CYANAMID CO (8)· patent assignee history
2002–2006Patents assigned to BASF AG (5)· patent assignee history
2014–2019Patents assigned to UNIV NORTHWESTERN (5)· patent assignee history
2014–2019Patents assigned to CAMBRIA PHARMACEUTICALS INC (4)· patent assignee history
2014–2019Based in Bedford, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMERICAN CYANAMID CO | 8 | 1995–2000 |
| BASF AG | 5 | 2002–2006 |
| SQUIBB & SONS INC | 5 | 1988–1994 |
| UNIV NORTHWESTERN | 5 | 2014–2019 |
| CAMBRIA PHARMACEUTICALS INC | 4 | 2014–2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Princeton, New Jersey, US | 19 | 1988–2008 |
| Bedford, Massachusetts, US | 5 | 2014–2019 |